CSF1R and Leukoencephalopathy: While still relatively novel, microglial replacement therapy is a scientifically sound strategy and presents an exciting research opportunity that could lead to clinical translation, alleviation of symptoms and improving the life quality of individuals who are suffering from currently incurable CSF1R-related leukoencephalopathy.